Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 May 1;56(5):787-794.
doi: 10.1093/rheumatology/kew470.

More severe disease and slower recovery in younger patients with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy

Eleni Tiniakou  1 , Iago Pinal-Fernandez  1 , Thomas E Lloyd  1 , Jemima Albayda  1 , Julie Paik  1 , Jessie L Werner  1 , Cassie A Parks  2 , Livia Casciola-Rosen  1 , Lisa Christopher-Stine  1   3 , Andrew L Mammen  1   2   3
Affiliations

More severe disease and slower recovery in younger patients with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy

Eleni Tiniakou et al. Rheumatology (Oxford). .

Abstract

Objective: To study disease severity and response to therapy in a large cohort of patients with anti-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR)-associated myositis.

Methods: Muscle strength, creatine kinase levels and treatments were assessed in anti-HMGCR-positive patients at each clinical visit. Univariate and multivariate analyses were used to analyse the influence of clinical characteristics on strength and the change in strength over time. Whole exome sequencing was performed in a subset of patients.

Results: . Among 50 patients followed for ⩾2 years, only 22 (44%) reached full strength with immunosuppressive therapy; even among those with full strength, 55% continued to have CK levels in excess of 500 IU/l and only three could be tapered off immunosuppressive therapy. Both univariate and multivariate analysis showed that patients who were older at disease onset were stronger at all time points (P < 0.001) and improved faster (P < 0.008) than younger patients; a history of statin exposure was not independently associated with the improvement rate. Younger patients were more likely to have refractory disease (P = 0.02) than older patients. Among eight refractory patients with DNA available for testing, whole exome sequencing did not reveal pathogenic mutations in known dystrophy genes. The risk of cancer was not increased in anti-HMGCR myositis patients compared with the general population.

Conclusions: Anti-HMGCR myositis is usually a chronic disease requiring long-term immunosuppression. Although younger patients had more severe disease and a worse prognosis than older patients, they did not have evidence of a known co-existing muscular dystrophy to explain their persistent, and sometimes progressive, muscle weakness.

Keywords: autoantibodies; myopathy; polymyositis.

PubMed Disclaimer

Figures

F<sc>ig</sc>. 1
Fig. 1
Relationship between CK levels and anti-hydroxy-3-methylglutaryl-coenzyme A reductase titres at first and follow-up visits
F<sc>ig</sc>. 2
Fig. 2
Survival analysis of strength recovery over time depending on the age at onset of weakness
See this image and copyright information in PMC

References

    1. Christopher-Stine L, Casciola-Rosen LA, Hong G. et al. A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy. Arthritis Rheum 2010;62:2757–66. - PMC - PubMed
    1. Mammen AL, Chung T, Christopher-Stine L. et al. Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy. Arthritis Rheum 2011;63:713–21. - PMC - PubMed
    1. Mammen AL. Statin-associated autoimmune myopathy. N Engl J Med 2016;374:664–9. - PubMed
    1. Mammen AL, Pak K, Williams EK. et al. Anti-HMG-CoA reductase antibodies are rare in statin users, including those with self-limited musculoskeletal side-effects. Arthritis Care Res 2011;64:269–72. - PMC - PubMed
    1. Werner JL, Christopher-Stine L, Ghazarian SR. et al. Antibody levels correlate with creatine kinase levels and strength in anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy. Arthritis Rheum 2012;64:4087–93. - PMC - PubMed

Publication types

MeSH terms

Substances